Outcome indicators for cross linking in pediatric keratoconus
Frontiers in Medicine · 12.05.2023 · 10
DOI: 10.3389/fmed.2023.1149641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 12.05.2023. Verfasst von Denise Wajnsztajn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the predictive factors for successful corneal collagen cross-linking (CXL) in pediatric patients with Keratoconus (KC).
Methods
This retrospective study was conducted using a prospectively built database. Patients (18 years old or younger) underwent CXL for KC between 2007 and 2017, with a 1-year follow-up period or longer. The outcomes included changes in Kmax (delta [Δ] Kmax = Kmax last − Kmax pre ) and LogMAR visual acuity (ΔLogMAR = LogMAR last − LogMAR pre ). The effects of CXL type (accelerated or non-accelerated), demographics (age, sex, background of ocular allergy, ethnicity), preoperative LogMAR visual acuity, maximal corneal power (Kmax), pachymetry (CCT pre ), refractive cylinder, and follow-up (FU) time on the outcomes were analyzed.
Results
One hundred thirty-one eyes of 110 children were included (mean age, 16 ± 2 years; range, 10–18 years). Kmax and LogMAR improved from baseline to last visit: from 53.81 D ± 6.39 D to 52.31 D ± 6.06 D ( p < 0.001) and from 0.27 ± 0.23 LogMAR units to 0.23 ± 0.19 LogMAR units ( p = 0.005), respectively. A negative ΔKmax (meaning corneal flattening) was associated with a long FU, low CCT pre , high Kmax pre , high LogMAR pre, and non-accelerated CXL on univariate analysis. High Kmax pre and non-accelerated CXL were associated with negative ΔKmax in the multivariate analysis. A negative ΔLogMAR (meaning vision improvement) was associated with a high LogMAR pre in univariate analysis.
Conclusion
CXL is an effective treatment option in pediatric patients with KC. Our results showed that the non-accelerated treatment was more effective than the accelerated treatment. Corneas with advanced disease had a greater effect on CXL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Zitieren
APA
Wajnsztajn, D., Shmueli, O., Tarnovsky, Y., Frucht-Pery, J., & Solomon, A. (2023). Outcome indicators for cross linking in pediatric keratoconus. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1149641
Vancouver
Wajnsztajn D, Shmueli O, Tarnovsky Y, Frucht-Pery J, Solomon A. Outcome indicators for cross linking in pediatric keratoconus. Frontiers in Medicine. 2023;10. doi:10.3389/fmed.2023.1149641
BibTeX
@article{Wajnsztajn2023,
author = {Wajnsztajn, Denise and Shmueli, Or and Tarnovsky, Yehuda and Frucht-Pery, Joseph and Solomon, Abraham},
title = {Outcome indicators for cross linking in pediatric keratoconus},
journal = {Frontiers in Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fmed.2023.1149641}
}
EUVIMED